登录 注册 会员服务 联系我们

Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma

  • Published:2022-10-29 Issue:2 Volume:64 Page:407-414
  • ISSN:1042-8194
  • Container-title:Leukemia & Lymphoma
  • language:en
  • Short-container-title:Leukemia & Lymphoma

Author:

Bici Anisa1,Pianko Matthew J.2ORCID,Nachar Victoria R.3

Affiliation:

1. Department of Pharmacy Services, Michigan Medicine and the University of Michigan College of Pharmacy, Ann Arbor, MI, USA

2. Division of Hematology and Oncology, Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA

3. Department of Pharmacy Services, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA

Funder

National Institutes of Health: National Institute of Aging

National Cancer Institute

National Center for Advancing Translational Sciences

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bortezomib/dexamethasone/lenalidomide;Reactions Weekly;2024-06-29
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3